Medtronic Pays $85M Settlement in Infuse Lawsuit

Medtronic has agreed to pay $85 million to resolve a class action claim filed in December 2008 by its shareholders.

Advertisement

The suit was filed by the Minneapolis Firefighters Relief Association, alleging misrepresentation and omissions by the company. Under the settlement, Medtronic denies any misrepresentations or omissions.

The Firefighters Relief Association alleged that the company artificially inflated its stock price during an off-label promotion for its bone morphogenic protein product Infuse, according to a Mass Device report.

More Articles on Orthopedic Devices:

Ascendx Spine Signs Distribution Agreement With Swiss Company

5 Spine-Focused Device Company 2011 Financial Reports

Benvenue Medical Enrolls 250 Patients in Kyphoplasty Trial

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.